Abstract
Cinnamic acids have been identified as interesting compounds with cytotoxic, anti-inflammatory, and antioxidant properties. Lipoxygenase pathway, catalyzing the first two steps of the transformation of arachidonic acid into leukotrienes is implicated in several processes such as cell differentiation, inflammation and carcinogenesis. Development of drugs that interfere with the formation or effects of these metabolites would be important for the treatment of various diseases like asthma, psoriasis, ulcerative colitis, rheumatoid arthritis, atherosclerosis, cancer, and blood vessel disorders. Till now, asthma consists of the only pathological case in which improvement has been shown by lipoxygenase LO inhibitors. Thus, the research has been directed towards the development of drugs that interfere with the formation of leukotrienes.
In order to explore the anti-inflammatory and cytotoxic effects of antioxidant acrylic/cinnamic acids a series of derivatives bearing the appropriate moieties have been synthesized via the Knoevenagel condensation and evaluated for their biological activities. The compounds have shown important antioxidant activity, anti-inflammatory activity and very good inhibition of soybean lipoxygenase while some of them were tested for their anticancer activity.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Yoshimatsu K, Yamaguchi A, Yoshino H, Koyanagi N, Kitoh K (1997) Mechanism of action of E7010, an orally active sulfonamide antitumor agent: inhibition of mitosis by binding to the colchicine site of tubulin. Cancer Res 7:208–3213
Hideki Tanaka H, Ohshima N, Ikenoya M, Komori K, Katoh F, Hidaka H (2003) HMN-176, an active metabolite of the synthetic antitumor agent HMN-214, restores chemosensitivity to multidrug-resistant cells by targeting the transcription factor NF-Y. Cancer Res 63: 6942–6947
Han DC, Lee MY, Shin KD, Jeon SB, Kim JM, Son KH, Kim HC, Kim HM, Kwon BM (2004) 20-Benzoyloxycinnamaldehyde induces apoptosis in human carcinoma via reactive oxygen species. J Biol Chem 279:6911–6920
Bandgar BP, Gawande SS, Bodade RG, Totre JV, Khobragade CN (2010) Synthesis and biological evaluation of simple methoxylated chalcones as anticancer, anti-inflammatory and antioxidant agents. Bioorg Med Chem 18: 1364–1370
Cheng JH, Huang AM, Hour TC, Yang SC, Pu YP, Lin CN (2010) Antioxidant xanthone derivatives induce cell cycle arrest and apoptosis and enhance cell death induced by cisplatin in NTUB1 cells associated with ROS. Eur J Med Chem 46:1222–1231
Kanagalakshmi K, Premanathan M, Priyanka R, Hemalatha B, Vanangamudi A (2010) Synthesis, anticancer and antioxidant activities of 7-methoxyisoflavanone and 2,3-diarylchromanones. Eur J Med Chem 45:2447–2452
Karali N, Guzel Ö, Özsov N, Özbey S, Salman A (2010) Synthesis of new spiroindolinones incorporating a benzothiazole moiety as antioxidant agents. Eur J Med Chem 45:1068–1077
Ford-Hutchinson AW, Gresser M, Young RN (1994) 5-Lipoxygenase. Annu Rev Biochem 63:383–417
Batt DG (1992) 5-Lipoxygenase inhibitors and their anti-inflammatory activities. Prog Med Chem 29:1–63
Kühn H (2007) Lipoxygenases. In: Marks F, Fürstenberger G (eds) Prostaglandins, laukotrienes and other eicosanoids: from biogenesis to clinical application. Wiley, Weinheim, Germany
Webb EC (1992) Enzyme Nomenclature 1992. Recommendations of the nomenclature Committee of the International Union of Biochemistry and Molecular Biology on the nomenclature and classification of the enzymes. Acad Press, San Diego, CA
Kuhn H (2000) Structural basis for the positional specificity of lipoxygenases. Prostaglandins Other Lipid Mediat 62:255–270
Kuhn H, Chaitidis P, Roffeis J, Walther M (2007) Arachidonic acid metabolites in the cardiovascular system: the role of lipoxygenase isoforms in atherogenesis with particular emphasis on vascular remodeling. J Cardiovasc Pharmacol 50:609–620
Pace-Asciak CR, Asotra S (1989) Biosynthesis, catabolism, and biological properties of HPETEs, hydroperoxide derivatives of arachidonic acid. Free Radic Biol Med 7:409–433
Radmark O, Samuelsson B (2007) 5-Lipoxygenase: regulation and possible involvement in atherosclerosis. Prostaglandins Other Lipid Mediat 8:162–174
Grivennikov SI, Greten FR, Karin M (2010) Immunity, inflammation, and cancer. Cell 140:883–899
Grivennikov SI, Karin M (2010) Inflammation and oncogenesis: a vicious connection. Curr Opin Genet Dev 20:65–71
Brash AR (1999) Lipoxygenases: occurrence, functions, catalysis, and acquisition of substrate. J Biol Chem 274:23679–23682
Norel X, Brink C (2004) The quest for new cysteinylleukotriene and lipoxin receptors: recent clues. Pharmacol Ther 103:81–94
Vera-Ramirez L, Sanchez-Rovira P, Ramirez-Tortosa MC, Ramirez-Tortosa CL, Granados-Principal S, Lorente JA, Quiles JL (2011) Free radicals in breast carcinogenesis, breast cancer progression and cancer stem cells. Biological bases to develop oxidative-based therapies. Crit Rev Oncol Hematol 80:347–368
Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB (2010) Oxidative stress, inflammation, and cancer: how are they linked? Free Radic Biol Med 49:1603–1616
Pontiki E, Hadjipavlou-Litina D (2006) Antioxidant and anti-inflammatory activity of aryl-acetic and hydroxamic acids as novel lipoxygenase inhibitors. Med Chem 2:251–264
Pontiki E, Hadjipavlou-Litina D (2007) Synthesis and pharmacochemical evaluation of novel aryl-acetic acids inhibitors of lipoxygenase and antioxidants and anti-inflammatory agents. Biorg Med Chem 15:5819–5827
Pontiki E, Hadjipavlou-Litina D, Litinas K, Nicolotti O, Carotti A (2011) Design, synthesis and pharmacobiological evaluation of novel acrylic acid derivatives acting as lipoxygenase and cyclooxygenase-1 inhibitors with antioxidant and anti-inflammatory activities. Eur J Med Chem 46:191–200
Pontiki E, Hadjipavlou-Litina D (2005) Lipoxygenases (LOs): an heterogenous family of lipid peroxidizing enzymes implicated in cell differentiation, inflammation, asthma, carcinogenesis, atherogenesis. An interesting target for the development of promising drugs. Curr Enh Inh 1:309–328
Pontiki E, Hadjipavlou-Litina D (2013) Targeting lipoxygenases (LOs): drug design and discovery. Curr Enz Inh 9:89–105
Taraporewala IB, Kauffman JM (1990) Synthesis and structure-activity relationships of anti-inflammatory 9,10-dihydro-9-oxo-2-acridine-alkanoic acids and 4-(2-carboxyphenyl)aminobenzenealkanoic acids. J Pharm Sci 79:173–178
Winter CA (1965) Anti-inflammatory testing methods: comparative evaluation of indomethacin and other agents. In: Garattini S, Dukes MNG (eds) International symposium on non-steroidal anti-inflammatory drugs. Excerpta Medica Foundation, Amsterdam
Kuroda T, Suzuki F, Tamura T, Ohmori K, Hosoe H (1992) A novel synthesis and potent antiinflammatory activity of 4-hydroxy-2(1H)-oxo-1-phenyl-1,8-naphthyridine-3-carboxamides. J Med Chem 5:1130–1136
Pontiki E, Hadjipavlou-Litina D, Geromichalos G, Papageorgiou A (2009) Anticancer activity and quantitative-structure activity relationship (QSAR) studies of a series of antioxidant/anti-inflammatory aryl-acetic and hydroxamic acids. Chem Biol Drug Des 74:266–275
Papazisis KT, Geromichalos GD, Dimitriadis KA, Kortsaris AH (1997) Optimization of the sulforhodamine B colorimetric assay. J Immunol Methods 208:151–158
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this protocol
Cite this protocol
Hadjipavlou-Litina, D., Pontiki, E. (2015). Aryl-Acetic and Cinnamic Acids as Lipoxygenase Inhibitors with Antioxidant, Anti-inflammatory, and Anticancer Activity. In: Armstrong, D. (eds) Advanced Protocols in Oxidative Stress III. Methods in Molecular Biology, vol 1208. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-1441-8_26
Download citation
DOI: https://doi.org/10.1007/978-1-4939-1441-8_26
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-1440-1
Online ISBN: 978-1-4939-1441-8
eBook Packages: Springer Protocols